FDA Philippines Medical Device Registration: Requirements, Process, Classification & Compliance Guide (2026)

To successfully launch a medical device in the Philippine market, there are certain regulatory requirements that need to be fulfilled. The FDA Philippines medical device registration is conducted using a risk-based approach, in which the device’s classification determines everything.

The FDA Philippines operates under a risk-based classification system with the ASEAN Medical Device Directive (AMDD). Under this system, medical devices are classified from Class A to Class D. The classifications are based on the level of regulatory control, documentation, testing, and approval process involved. Certain should be met by the manufacturer, including a License to Operate (LTO).

The guide describes how to register your medical device with the FDA Philippines step-by-step. This includes the classification of the medical device, the requirement for registration, documentation of the CSDT, submitting the application, payment of fees, post-market requirements, and even cybersecurity issues.

What Is the FDA Philippines Medical Device Registration Framework?

The FDA Philippines medical device registration framework outlines the necessary procedures that manufacturers, importers, and distributors have to comply with for their devices to be legally sold in the country. The system is guided by the Administrative Order No. 2018-0002 and adopts the risk-based approach of the ASEAN Medical Device Directive (AMDD).

Key Regulations for Medical Device Registration in the Philippines

The key regulations for medical device registration in the Philippines include:

• AO No. 2018-0002: Lays out the structure for the notification and registration of medical devices.
• Republic Act No. 9711: Grants the Philippine FDA power to regulate health products.
• FDA Circular No. 2020-001: Sets out requirements for the electronic submission process.
• AO No. 2020-0033: Addresses the post-market surveillance requirements.

ASEAN Medical Device Directive (AMDD) Requirements in the Philippines

The Philippines follows the ASEAN Medical Device Directive (AMDD) as the regulatory framework for medical devices. Manufacturers must comply with the applicable AMDD requirements and prepare their technical documentation using the ASEAN Common Submission Dossier Template (CSDT).

The AMDD framework covers key requirements, including:

• Risk-based device classification
• Essential principles of safety and performance
• Technical and manufacturing information
• Risk management and clinical evidence
• Labelling and post-market surveillance

What Is the Difference Between Medical Device Notification and Registration?

The regulatory pathway depends mainly on the device’s risk classification. Class A devices generally follow a notification pathway, while Class B, C, and D devices require registration and a more detailed technical review.

How Are Medical Devices Classified Under Philippine Regulations?

Medical device classification dictates the strictness of your technical evaluation route, the documentary burden of your CSDT dossier, and the exact government fees and processing timelines required for market clearance.

Risk-Based Classification: Classes A, B, C, and D

In compliance with AMDD guidelines, the CDRRHR categorizes all medical devices into four distinct risk tiers based on their intended use, duration of bodily contact, and invasiveness:

• Class A (Low Risk): Non-sterile, non-measuring devices such as standard hospital beds, manual wheelchairs, non-prescription spectacles, and basic tongue depressors.
• Class B (Low-to-Moderate Risk): Devices including hypodermic needles, diagnostic ultrasound systems, and standard clinical infusion pumps.
• Class C (Moderate-to-High Risk): Advanced systems such as pulmonary ventilators, orthopedic and dental bone implants, diagnostic anesthesia workstations, and blood transfusion circuits.
• Class D (High Risk): Critical, life-sustaining devices including implantable cardiac pacemakers, automated implantable cardioverter-defibrillators (AICDs), and high-risk biological heart valve substitutes.

Rules and Criteria for Determining Device Class

Classification is determined by systematically applying the risk-based classification rules outlined in the AMDD framework. Evaluators look at specific technical criteria:

• Whether a device is active or non-active.
• Whether it depends on a source of energy other than gravity or the human body.
• Its level of invasiveness, distinguishing between surgical and non-surgical body contact.
• Whether contact duration is transient (less than 60 minutes), short-term (up to 30 days), or long-term (exceeding 30 days).
• Whether the device supports or sustains vital central physiological functions.

Implications of Classification on Registration Routes

The risk tier directly defines your administrative pathway and regulatory obligations:

• Class A: Undergoes an electronic notification process yielding a Certificate of Medical Device Notification (CMDN).
• Classes B, C, and D: Require full technical registration, culminating in a Certificate of Medical Device Registration (CMDR) backed by rigorous design verification data.

What Do You Need Before Registering a Medical Device in the Philippines?

Before registering a medical device with the FDA Philippines, applicants need to meet several basic regulatory requirements. These may include an appropriate License to Operate (LTO), a Philippine-based authorised representative for foreign manufacturers, and supporting quality management documents.

License to Operate (LTO) Requirements 

Companies involved in manufacturing, importing, distributing, or selling medical devices may need an FDA License to Operate (LTO) for their specific regulated activities. The LTO confirms that the establishment meets the FDA’s requirements for carrying out those activities.

Depending on the establishment and its activities, applicants may need to demonstrate:

• Suitable storage and warehousing facilities
• Appropriate distribution and transportation controls
• Quality management procedures
• Qualified personnel
• Applicable Good Distribution Practice (GDP) requirements

Philippine Authorised Representative Requirements 

Foreign manufacturers generally need a Philippine-based authorised representative or local establishment to support their regulatory activities in the country. The local representative acts as a point of contact between the manufacturer and the FDA.

Their responsibilities may include:

• Coordinating the registration or notification application
• Communicating with the FDA
• Maintaining relevant regulatory records
• Supporting complaint and adverse-event reporting
• Assisting with post-market regulatory requirements

Quality Management Documentation 

Applicants need to provide appropriate evidence that the medical device is manufactured under controlled quality processes. ISO 13485 certification may be required or requested depending on the applicable device and regulatory pathway.

Relevant quality documentation can cover:

• Design and development controls
• Manufacturing processes
• Quality assurance procedures
• Risk management
• Production and distribution controls.

What Documents Are Required for FDA Philippines Registration?

Applicants must prepare a complete set of administrative, legal, technical, and safety documents before submitting a medical device application to the FDA Philippines. Missing or incorrect documents can delay the review process or result in the application being returned for correction.

Administrative and Legal Documents

• Certificate of Free Sale (CFS): A valid CFS or equivalent document from the health authority in the device’s country of origin. Where required, the document must be authenticated through an Apostille or the appropriate Philippine consular process.
• Letters of Authorization (LOA): A formal document confirming the relationship between the foreign manufacturer or product owner and the Philippine-based importer or authorised representative.
• Distributorship Agreements: Documents that define the distributor’s role, responsibilities, and relationship with the manufacturer, including responsibilities for post-market activities.

Technical and Safety Documentation

• Essential Principles Checklist: A checklist showing how the medical device meets the applicable safety, performance, and design requirements.
• Device Description and Specifications: Information about the device’s design, components, materials, intended use, and technical specifications, including the patients and medical conditions for which it is intended.
• Labelling and User Manuals: Product labels, packaging artwork, and instructions for use containing the required information, such as the manufacturer’s details, product identification, lot or batch information, storage conditions, and applicable registration or notification details.
• Risk Management File (ISO 14971): Documentation showing how potential risks and hazards have been identified, assessed, controlled, and monitored throughout the device’s lifecycle.
• Clinical and Performance Evaluation Data: Evidence supporting the device’s safety and performance. Depending on the device, this may include laboratory or bench testing, biocompatibility testing under ISO 10993, electrical safety testing under applicable IEC standards, and clinical evaluation data.

What Is the Step-by-Step Registration Process to Clear the FDA?

Navigating the application lifecycle requires following a strict, multi-stage submission and evaluation workflow.

Step 1: Account Creation and Submission via the FDA e-Portal V2

The applicant or designated local representative accesses the official online portal system (e-Portal V2) to establish a secure corporate profile. Digital application forms are completed, and all administrative, legal, and CSDT technical files are uploaded as encrypted PDF documents.

Step 2: Documentary Pre-Assessment and Fee Payment

CDRRHR intake officers conduct an administrative pre-assessment to verify that all required documents have been uploaded in the correct format. Key steps during this phase include:

• Verification of digital document completeness against statutory checklists.
• Generation of an official Order of Payment once initial compliance is established.
• Settlement of filing fees—which scale depending on risk class and include a 1% Legal Research Fund (LRF) fee—through authorized government payment channels.

Step 3: Technical Evaluation by CDRRHR Reviewers

Once proof of payment is validated, the application enters the formal queue for scientific review. Evaluators examine the CSDT dossier, checking design validation summaries, sterilization records, biocompatibility data, and risk management files for technical adequacy.

Step 4: Deficiency Management and Response Protocols

If technical evaluators identify missing data, non-compliant labeling, or incomplete test results, an official deficiency letter is issued. Operational rules during this phase include:

• Granting a non-extendable compliance window (typically 30 to 90 calendar days depending on the governing administrative issuance).
• Requiring complete, corrected documentation addressing every highlighted audit point.
• Triggering automatic application disapproval if responses fail to arrive within the designated timeframe.

Step 5: Approval and Issuance of the Certificate of Product Registration (CPR)

Upon successful completion of the technical audit, the application is cleared for final sign-off. The agency officially approves the dossier and issues the formal market authorization document (CMDN for Class A; CMDR for Classes B, C, and D).

What Are the Timelines, Fees, and Validity Periods for Your Registration?

Budgeting operational capital and commercial timelines requires a realistic assessment of statutory schedules and fee structures.

Standard Processing Schedules and Common Bottlenecks

• Class A Notifications: Typically require 1 to 2 months from initial digital submission to final CMDN issuance.
• Classes B, C, and D Registrations: Average 6 to 9 months under standard review tracks, which can extend to 12 months if multiple technical deficiency rounds occur.
• Common Bottlenecks: Delays most frequently stem from poorly formatted CSDT dossiers, unauthenticated foreign certificates, lack of local labeling compliance, or sluggish responses to deficiency notifications.

Government Filing Fees and Variances by Device Class

Government fees vary across risk tiers based on specific economic structures:

• Class A Notifications: Involve lower base charges ranging from approximately PHP 7,500 to 81,000 inclusive of LRF depending on notification tracks.
• Classes B, C, and D Registrations: Incur higher processing fees that reflect the depth of technical evaluation required.
• Additional Costs: Companies must also budget for subsequent post-approval variation and renewal fees.

CPR Validity Periods and Post-Approval Maintenance

Initial market authorization certificates carry a multi-year validity lifespan, typically set at 5 years. Regulatory holders must track expiration dates meticulously, initiating renewal submissions several months before expiration to prevent commercial supply interruptions.

How Can You Maintain Medical Device Compliance After Registration?

Medical device compliance in the Philippines continues after FDA authorisation through post-market surveillance, safety reporting, product recalls, corrective actions, and timely renewal or variation of the device authorisation. Manufacturers and market authorisation holders must maintain appropriate records, monitor device performance, address identified risks, and keep their regulatory information current.

Post-Market Surveillance and Safety Reporting

Post-market surveillance helps identify safety, quality, and performance issues after a device enters the Philippine market.

Manufacturers and market authorisation holders should:

• Monitor product complaints, adverse events, and device performance.
• Maintain complaint records and investigate reported problems.
• Assess whether an incident indicates a potential safety or quality concern.
• Take appropriate corrective action when a device presents a risk.
• Submit reports to the FDA when required under applicable post-market surveillance requirements.

Product Recalls and Corrective Actions

When a medical device is found to be defective or presents a health risk, the FDA may require a recall or other corrective action.

The recall process may involve:

• Identifying the affected device, batch, lot, or units.
• Assessing the potential health risk.
• Stopping further distribution or sale of affected products.
• Notifying distributors, healthcare facilities, and other relevant users.
• Retrieving affected products from the supply chain.
• Correcting, replacing, or disposing of affected products as appropriate.
• Maintaining recall records and providing required information to the FDA.

The FDA’s draft recall guidelines propose an initial recall report within 24 hours of detecting the recall trigger, followed by a supplemental submission within 10 working days. These timelines should be presented as proposed requirements because the document is a draft for comments.

Renewals and Post-Approval Variations

Keeping the FDA authorisation current is another important part of ongoing compliance.

• Class A devices: CMDN renewal applies.
• Class B, C, and D devices: CMDR renewal applies.
• The FDA’s CDRRHR service information provides a 5-year validity period for medical device renewal.
• Manufacturers should monitor certificate expiry dates and submit renewal applications in advance.
• Changes to approved product information, manufacturing details, or other regulated particulars may require a variation or other FDA regulatory action.
• Proposed changes should be reviewed against the applicable FDA requirements before implementation.

How Does Qualysec Support FDA Philippines Medical Device Registration? 

Qualysec is a specialized CREST-accredited cybersecurity firm recognized for delivering advanced penetration testing, vulnerability assessments, and compliance-focused security solutions. For health-tech innovators and medical device manufacturers preparing technical dossiers, Qualysec provides crucial technical backing through:

• Hybrid Penetration Testing: Combining rigorous manual testing by certified ethical hackers with advanced automated analysis to uncover hidden security flaws in Software as a Medical Device (SaMD) and connected hospital systems.
• Threat Modeling and Risk Architecture: Assessing trust boundaries and data-flow pathways to ensure software defenses adequately protect against multi-patient harm and data breaches.
• SBOM and Compliance Support: Assisting developers with Software Bill of Materials (SBOM) verification and security documentation aligned with international pre-market cybersecurity standards.

By identifying digital vulnerabilities and hardening software architecture before submission, Qualysec helps medical technology companies mitigate compliance hurdles, secure their digital assets, and accelerate smooth market deployment.

Conclusion

Securing medical device authorization in Southeast Asia’s rapidly expanding healthcare market requires meticulous attention to regulatory detail, comprehensive technical documentation, and strict adherence to statutory review procedures. By mastering risk-based classification tiers, maintaining certified quality systems, and partnering with experienced local representatives, manufacturers can successfully introduce innovative health technologies to the public. 

Navigating this complex regulatory journey with precision ensures long-term operational compliance, commercial growth, and an unwavering commitment to patient safety and clinical excellence across the region.

Frequently Asked Questions

1. How do I register a medical device in the Philippines?

To register a medical device, first determine its AMDD risk class, secure the required LTO and local representation, prepare the CSDT and supporting documents, and submit the application through the FDA’s designated electronic system. Class A devices generally follow notification, while Classes B–D require registration.

2. Is CSDT mandatory for medical device registration in the Philippines?

The ASEAN Common Submission Dossier Template (CSDT) is used for preparing the technical documentation required under the AMDD framework adopted by the Philippines. The dossier contains information on the device, safety and performance, risk management, and supporting evidence.

3. What are the medical device classes in the Philippines?

The Philippines uses four AMDD risk classes: Class A, Class B, Class C, and Class D. Class A represents the lowest risk, while Class D covers the highest-risk devices and generally requires the most extensive regulatory review.

4. How long does FDA medical device registration take in the Philippines?

Processing time depends on the device classification and completeness of the submission. Class A notifications may take around 1–2 months, while Classes B, C, and D can take approximately 6–9 months under standard review and longer when technical deficiencies require additional responses.

5. What happens after a medical device is registered in the Philippines?

Compliance continues after authorisation through post-market surveillance, complaint and adverse-event monitoring, recalls or corrective actions when necessary, and timely renewal or variation of the FDA authorisation. Medical device renewals listed by the CDRRHR have a 5-year validity period.